Risk Factors in HIV/AIDS Patients With Cryptococcal Meningitis

BMC Infectious Diseases - United Kingdom
doi 10.1186/1471-2334-14-s4-p29
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Factors Associated With Early Mycological Clearance in HIV-associated Cryptococcal Meningitis

PLoS ONE
Multidisciplinary
2017English

The Use of Mannitol in HIV-infected Patients With Symptomatic Cryptococcal Meningitis

Drug discoveries & therapeutics
MedicineToxicologyPharmaceuticsPharmacology
2016English

Emerging Concepts in HIV-associated Cryptococcal Meningitis

Current Opinion in Infectious Diseases
Infectious DiseasesMicrobiology
2019English

Recent Advances in Managing HIV-associated Cryptococcal Meningitis

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2019English

Amphotericin B for Cryptococcal Meningitis in HIV Positive Patients: Low Dose Versus High Dose

Indian Journal of Critical Care Medicine
Critical CareIntensive Care Medicine
2007English

Factors Associated With Adherence to HAART in Patients With HIV/Aids

Jornal Brasileiro de Doenças Sexualmente Transmissíveis
2011English

Risk Factors Associated With Hypovitaminosis D in HIV/aids-infected Adults

Archives of endocrinology and metabolism
EndocrinologyMetabolismDiabetes
2015English

Cryptococcal Meningitis in a Patient With Sarcoidosis

Baylor University Medical Center Proceedings
Medicine
2016English

Peripheral Blood CD4+ T-Lymphocyte Count Influences Cerebrospinal Fluid Cellular Response in Patients With HIV-related Cryptococcal Meningitis

Journal of the International AIDS Society
EnvironmentalPublic HealthInfectious DiseasesOccupational Health
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy